Khang & Khang LLP Announces Lawsuit against Cempra, Inc. (NASDAQ:CEMP)

Khang & Khang LLP announces a class action lawsuit against Cempra, Inc. (NASDAQ:CEMP). Investors who purchased or otherwise acquired shares between May 1, 2016 and November 1, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the January 3, 2017 lead plaintiff motion deadline. The Complaint alleges that during the Class Period, Cempra made false and/or misleading statements and/or failed to disclose that solithromycin posed significant safety risks for hepatotoxicity, so the Company’s public statements were materially false and misleading at all relevant times.

On last trading day, Cempra, Inc. (NASDAQ:CEMP) traded 19.55 Million shares and was closed at $2.80 per share. Company stock is -91.33% away from its one year high and is moving 9.80% ahead of its one year low. Stock monthly performance is recorded as -56.92% while its performance in last one week is -52.54%. CEMP quarterly performance is -88.27% while firm’s price to sale ratio is 8.78 and price to book ratio is 0.70.

Analyst’s Analysis on Cempra, Inc. (NASDAQ:CEMP)
Number of analysts are eying on this stock and after detailed observation, they have given the stock mean target price of $13.77 while their mean recommendation is 2.90 (1=Buy, 5=sell). The consensus recommendation by Thomson Reuters analysts is Hold and their mean rating for the stock is 3.07 on scale of 1-5.

Johnson & Johnson (NYSE:JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 24th, to review fourth-quarter and full-year results. Alex Gorsky, Chairman and Chief Executive Officer; Dominic Caruso, Executive Vice President, Chief Financial Officer and Joseph J. Wolk, Vice President, Investor Relations, will host the call.

Johnson & Johnson (NYSE:JNJ) shares moved to $115.21 after starting the day at $115.80 on Friday. The weekly volatility of JNJ is 0.80% and monthly volatility is 1.14%. Its weekly performance is -0.20% while year to date (YTD) performance is 15.33%.

What Analysts Say About Johnson & Johnson (NYSE:JNJ)
Stock has got outperform rating from 4 analysts of Thomson Reuters whereas 14 analysts given hold rating to the stock. Analyst’s mean target price for the firm is $125.16 while analysts mean recommendation is 2.50.

On last trading day, Archer-Daniels-Midland Company (NYSE:ADM) traded 2.52 Million shares and was closed at $45.65 per share. Company stock is -3.97% away from its one year high and is moving 57.71% ahead of its one year low. Stock monthly performance is recorded as 5.60% while its performance in last one week is 1.04%. ADM quarterly performance is 9.04% while firm’s price to sale ratio is 0.42 and price to book ratio is 1.53.

Analyst’s Analysis on Archer-Daniels-Midland Company (NYSE:ADM)
Number of analysts are eying on this stock, and after detailed observation, they have given the stock mean target price of $45.54 while their mean recommendation is 2.70 (1=Buy, 5=sell). The consensus recommendation by Thomson Reuters Analysts is Hold for ADM and their mean rating for the stock is 2.67 on scale of 1-5.

Dominion Resources, Inc. (NYSE:D) shares moved to $76.59 after starting the day at $77.04 on Friday. The weekly volatility of D is 1.01% and monthly volatility is 1.33%. Firm weekly performance is -0.05% while year to date (YTD) performance is 17.67%. Company net profit margin stands at 18.10% whereas its Gross Margin is 97.30%. This year company’s Earnings per Share (EPS) growth is 42.70% and next year’s estimated EPS growth is 1.32%.

What Analysts Say About Dominion Resources, Inc. (NYSE:D)
Stock has got outperform rating from 3 analysts of Thomson Reuters whereas 13 analysts given hold rating to the stock. Analyst’s mean target price for D is $78.29 while analysts mean recommendation is 2.50.

Leave a Reply

Your email address will not be published. Required fields are marked *